KK2 - Nice find. Glad you posted the link. A couple of yrs ago DM said there was 3 scientific reports that would be out shortly, I wondered if this was one of them. We all whined and moaned about them not delivering on their promises even though we new it was completely out of their control. This is the part that helps make us all a little insane. This study was obviously done prior to June of 2013 as they refer to the company being in a Phase II study and here we are 3 and a half years later reading about this study. It was published 30 Nov 2017. The BoM trial was not even mentioned.

What's even more interesting is that this study was well before Hepalink got involved with us and the study was done in Shanghai. This now brings up another thought that someone on this board posted about over the last couple of months, has someone from Hepa or close to them been doing all kinds of testing with RVX208 on their own for a number of yrs now?

This study is yet another reason I am sticking with my own market valuation. Most of you know that is far above what Beacon came out with a couple of weeks ago.

Thanks again KK2, nice find.

dyodd

tada